Observational, Non-Interventional Study Supporting Validation of eVO2peak Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET)
Eligible age
18+ yrs
Accepts
All genders
Locations
8 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
In this study, the hypothesis being explored is that peak VO2 and potentially other CPET parameters can be accurately estimated from biosignals (namely, motion from accelerometers and cardiopulmonary variables from EKG) collected during activities of daily living using FDA-cleared wearable biosensors worn by study participants. This study will aim to collect data using wearable biosensors from standard of care patients toward the development of an algorithm that can estimate peak VO2 (eVO2peak) from biosensor data. In addition, this study will explore to further develop other estimated measurements typically reported in CPET, such as VE/VCO2 slope, as well as selected and measures of Left Ventricular Function (diastolic and systolic) typically reported in echocardiogram; instead using wearable biosensors from standard of care testing. A total of 2000 participants will be enrolled including: (Normal) 100 participants, self-reported healthy male and female participants aged 18 to 80 and (Standard of Care) 1900 participants.
Sponsor: Prolaio
You may qualify if…
- ✓ 1. Willing and able to comply with protocol procedures and available for the duration of the study.
- ✓ 2. Willing to sign and date informed consent document for study participation.
- ✓ 3. Participant is undergoing the Cardiopulmonary Exercise Test (CPET), or an echocardiogram (Echo), or both CPET and Echo as Standard of Care
You may not qualify if…
- ✕ 1. Participant is pregnant, lactating or ≤30 days post-partum.
- ✕ 2. Participant has limited or no intrinsic sinus node function (i.e. chronic atrial pacing).
- ✕ If participant has an indwelling cardiac device and programming cannot be sufficiently ascertained to assure sinus node competence and lack of atrial pacing, the patient should be excluded.
- ✕ 3. Barostim (™) or similar noncardiac electrical pulse generating device in situ.
- ✕ 4. Complex congenital heart disease (even repaired or palliated) with the following exception:
- ✕ Biventricular physiology without severe valvar dysfunction (e.g. free pulmonary insufficiency) at the discretion of the investigator.
- ✕ 5. Any history of allergy to adhesive
- ✕ 6. Any cognitive or physical limitations that, in the opinion of the investigator, limits the participant's ability to fully follow study procedures and/or reach a respiratory exchange ratio of 1.0, or perform a maximal CPET in the judgement of the investigator, and/or any limitations pertaining to obtaining a complete Echo
Where it's recruiting
Source: ClinicalTrials.gov · NCT05678530 · last updated 2026-09-09